European Commission Clears Acquisition of Genzyme Corporation by sanofi-aventis
- Details
- Category: Sanofi
![Sanofi-aventis Sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
Sandoz announces phase II clinical trial for biosimilar version of rituximab
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK'786
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
New Bayer U.S. Innovation Center starts its operations
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
People to Actively Manage Their Type 2 Diabetes
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
Genzyme Financial Recovery Continues in Fourth Quarter
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
More Pharma News ...
- Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse®
- Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold
- Genzyme Statement on Discussions With Sanofi-Aventis
- US Food and Drug Administration extend review timeline for vandetanib
- KOMBIGLYZE™ XR Now Available in U.S. Pharmacies
- FDA grants supplemental approval for ACTEMRA
- Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases